Ausgabe 8/2018
Inhalt (22 Artikel)
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer
David Groheux, L. Biard, J. Lehmann-Che, L. Teixeira, F. A. Bouhidel, B. Poirot, P. Bertheau, P. Merlet, M. Espié, M. Resche-Rigon, C. Sotiriou, P. de Cremoux
The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
Christos Sachpekidis, Hoda Anwar, Julia Winkler, Annette Kopp-Schneider, Lionel Larribere, Uwe Haberkorn, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss
Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma
Sheng-Chieh Chan, Chih-Hua Yeh, Tzu-Chen Yen, Shu-Hang Ng, Joseph Tung-Chieh Chang, Chien-Yu Lin, Tsang Yen-Ming, Kang-Hsing Fan, Bing-Shen Huang, Cheng-Lung Hsu, Kai-Ping Chang, Hung-Ming Wang, Chun-Ta Liao
Preoperative [18F]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study
Jeong-Won Lee, Jeong-Yeol Park, Hyun Ju Lee, Jong Jin Lee, Seung Hwan Moon, Seo Young Kang, Gi Jeong Cheon, Hyun Hoon Chung
Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes
Sohyun Park, Jin Chul Paeng, Chang Hyun Kang, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, Dong Soo Lee
18F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics
Kambiz Rahbar, Ali Afshar-Oromieh, Martin Bögemann, Stefan Wagner, Michael Schäfers, Lars Stegger, Matthias Weckesser
The central zone has increased 68Ga-PSMA-11 uptake: “Mickey Mouse ears” can be hot on 68Ga-PSMA-11 PET
Daniele A. Pizzuto, Julian Müller, Urs Mühlematter, Niels J. Rupp, Antonia Töpfer, Ashkan Mortezavi, Hannes Nagel, Benedikt Kranzbühler, Daniel Eberli, Irene A. Burger
Feasibility of state of the art PET/CT systems performance harmonisation
Andres Kaalep, Terez Sera, Sjoerd Rijnsdorp, Maqsood Yaqub, Anne Talsma, Martin A. Lodge, Ronald Boellaard
Alphatherapy, the new impetus to targeted radionuclide therapy?
Jean-François Chatal, Françoise Kraeber-Bodéré, Michel Chérel, Ferid Haddad
Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study
Michael E. Autenrieth, Christof Seidl, Frank Bruchertseifer, Thomas Horn, Florian Kurtz, Benedikt Feuerecker, Calogero D’Alessandria, Christian Pfob, Stephan Nekolla, Christos Apostolidis, Saed Mirzadeh, Jürgen E. Gschwend, Markus Schwaiger, Klemens Scheidhauer, Alfred Morgenstern
ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab
Lei Kang, Dawei Jiang, Christopher G. England, Todd E. Barnhart, Bo Yu, Zachary T. Rosenkrans, Rongfu Wang, Jonathan W. Engle, Xiaojie Xu, Peng Huang, Weibo Cai
[18F]FDG PET/MR enterography for the assessment of inflammatory activity in Crohn’s disease: comparison of different MRI and PET parameters
Yan Li, Karsten Beiderwellen, Felix Nensa, Johannes Grüneisen, Gustav Dobos, Ken Herrmann, Thomas Lauenstein, Lale Umutlu, Jost Langhorst
Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia
Daniele Muser, Pasquale Santangeli, Simon A. Castro, Jackson J. Liang, Andres Enriquez, Thomas J. Werner, Gaetano Nucifora, Silvia Magnani, Tatsuya Hayashi, Erica S. Zado, Fermin C. Garcia, David J. Callans, Sanjay Dixit, Benoit Desjardins, Francis E. Marchlinski, Abass Alavi
Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT
Hiroshi Matsuda, Miho Murata, Yohei Mukai, Kazuya Sako, Hidetoshi Ono, Hiroshi Toyama, Yoshitaka Inui, Yasuyuki Taki, Hideo Shimomura, Hiroshi Nagayama, Amane Tateno, Kenjiro Ono, Hidetomo Murakami, Atsushi Kono, Shigeki Hirano, Satoshi Kuwabara, Norihide Maikusa, Masayo Ogawa, Etsuko Imabayashi, Noriko Sato, Harumasa Takano, Jun Hatazawa, Ryosuke Takahashi
Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment
Ivayla Apostolova, Catharina Lange, Per Suppa, Lothar Spies, Susanne Klutmann, Gerhard Adam, Michel J. Grothe, Ralph Buchert
TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis
Marcus Unterrainer, C. Mahler, L. Vomacka, S. Lindner, J. Havla, M. Brendel, G. Böning, B. Ertl-Wagner, T. Kümpfel, V. M. Milenkovic, R. Rupprecht, M. Kerschensteiner, P. Bartenstein, Nathalie L. Albert
Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects
Zhen Fan, Melanie Dani, Grazia D. Femminella, Melanie Wood, Valeria Calsolaro, Mattia Veronese, Federico Turkheimer, Steve Gentleman, David J. Brooks, Rainer Hinz, Paul Edison
Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer’s dementia in a memory clinic population
Lars Frings, Sabine Hellwig, Tobias Bormann, Timo S. Spehl, Ralph Buchert, Philipp T. Meyer
18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI
Serge Desarnaud, Charles Mellerio, Franck Semah, Agathe Laurent, Elisabeth Landre, Bertrand Devaux, Catherine Chiron, Vincent Lebon, Francine Chassoux
The impact of a Bayesian penalized-likelihood reconstruction algorithm on delayed-time-point Ga-68-PSMA PET for improved recurrent prostate cancer detection
Tiago Sampaio Vieira, Diogo Borges Faria, Fernando Azevedo Silva, Sérgio Barroso, Graça Fonseca, José Pereira Oliveira
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?
Anne-Ségolène Cottereau, Irene Buvat, Salim Kanoun, Annibale Versari, Olivier Casasnovas, Stephane Chauvie, Jérôme Clerc, Andrea Gallamini, Michel Meignan
Correction to: 18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI
Serge Desarnaud, Charles Mellerio, Franck Semah, Agathe Laurent, Elisabeth Landre, Bertrand Devaux, Catherine Chiron, Vincent Lebon, Francine Chassoux